Extracorporeal Membrane Oxygenation in children - a retrospective data analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031027

Enrollment

200

Registered

2023-06-27

Start date

2021-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terminal heart and/or lung failure

Interventions

Group 1: Children 0-18 years on extracorporeal membrane oxygenation (venoarterial and venovenous)

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Cardiovascular or pulmonary support with extracorporeal membrane oxygenation (ECMO). Time period of ECMO support from 30 January 2014 until 03 December 2021.

Exclusion criteria

Exclusion criteria: ECMO support of less than 24 hours. In part 1, no application of investigated medication.

Design outcomes

Primary

Measure	Time frame
Serum concentration and dose of vancomycin	—

Secondary

Measure	Time frame
Influencing factors on phramacokinetics Serum concentration and dose of midazolam, sufentanil	—

Countries

Germany

Contacts

Public ContactAlexej Bobrowski

Universitätsklinikum Freiburg

alexej.bobrowski@uniklinik-freiburg.de+49 761 270-43230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026